Same Cancer. Different Treatment. Here's Why.
Two people can have the same type of cancer but respond to very different treatments. Discover how biomarkers are helping doctors better understand cancer and make more personalized treatment decisions.
Imagine two people diagnosed with the same type of breast cancer.
They're close in age. Their cancers are diagnosed at similar stages. Yet their doctors recommend different treatments.
Why?
Because even when cancers have the same name, they aren't necessarily the same disease at the molecular level.
One person's cancer cells might have certain proteins that help them grow. Another person's cancer might carry genetic changes that make it vulnerable to a particular medication.
What if the key to treating cancer more effectively isn't just knowing where it started, but understanding what's happening inside the cancer itself?
That's the promise of biomarker testing, and it's changing the way we approach cancer care.
First, What Exactly Is a Biomarker?
Think of biomarkers as biological clues.
They're measurable substances or characteristics in the body, such as genes, proteins, or other molecules, that can provide information about a person's health or disease.
In cancer care, some biomarkers help doctors understand how a tumor behaves, whether certain treatments might work, or how cancer is responding to therapy.
Here's a simple way to think about it.
If cancer is a locked door, a biomarker may help doctors identify which key has the best chance of opening it.
Not every cancer has an identifiable target. And not every biomarker leads to a treatment.
But when the right information is available, it can make a meaningful difference.
Why Do Biomarkers Matter So Much?
For decades, cancer treatment decisions have relied heavily on where a cancer develops, how large it is, and whether it has spread.
Those factors still matter enormously.
But scientists have learned that cancers also have molecular characteristics that can influence how they grow and respond to treatment.
Biomarker testing can sometimes help doctors:
Choose treatments: Identify targeted therapies or immunotherapies that may be appropriate.
Avoid certain treatments: Recognize when a medication is less likely to be effective.
Understand a cancer's behavior: Learn more about its characteristics and potential risk of recurrence.
Monitor treatment: Track certain biological signals that may indicate whether treatment is working.
Explore clinical trials: Identify research studies designed for cancers with specific molecular features.
This approach is part of precision medicine, which uses information about a person's cancer to help guide care.
It's not about replacing traditional treatment. It's about making treatment decisions more informed.
Real Examples of Biomarkers Changing Cancer Care
This isn't just a scientific theory. Biomarker testing is already used in the treatment of several cancers.
Breast Cancer: HER2 and Hormone Receptors
Some breast cancers produce unusually high levels of a protein called HER2, which can encourage cancer cells to grow.
Testing for HER2 helps doctors determine whether certain HER2-targeted treatments may be effective.
Doctors also test for estrogen and progesterone receptors to determine whether hormone-based treatments might help.
Lung Cancer: EGFR and Other Genetic Changes
Some lung cancers contain changes in genes such as EGFR, ALK, or ROS1.
Identifying these changes may help doctors recommend targeted medications designed to interfere with specific cancer-growth pathways.
Colorectal Cancer: KRAS and Mismatch Repair
Certain KRAS gene changes can indicate that particular targeted drugs are unlikely to work.
Other biomarkers, including deficient mismatch repair (dMMR) and high microsatellite instability (MSI-H), may help identify cancers that could respond to certain immunotherapies.
The bigger lesson? Two people with the same type of cancer may need different treatment strategies.
How Is Biomarker Testing Done?
In many cases, doctors use a small sample of tumor tissue collected during a biopsy or surgery.
That sample is analyzed in a laboratory to look for specific genetic changes, proteins, or other characteristics.
Sometimes biomarker testing can be performed using a blood sample through a technique called a liquid biopsy.
Certain liquid biopsies look for fragments of tumor DNA circulating in the bloodstream.
This is an exciting development because it may allow doctors to gather information without another invasive tissue procedure.
However, liquid biopsies aren't appropriate for every cancer or every situation, and a negative blood test doesn't always mean a relevant biomarker isn't present.
Is Biomarker Testing the Same as Genetic Testing?
Not exactly, and this distinction is important.
Inherited genetic testing looks for changes in the DNA you were born with that may affect your risk of developing cancer.
Tumor biomarker testing looks for characteristics of an existing cancer that may help guide treatment.
Some tests overlap, and results from tumor testing may sometimes lead doctors to recommend inherited genetic testing.
But the two approaches generally answer different questions:
Am I at increased risk of developing cancer?
Versus:
What can we learn about this cancer to help guide my care?
Does Everyone With Cancer Need Biomarker Testing?
Not necessarily.
Biomarker testing is routinely recommended for some cancers and clinical situations. For others, it may be useful only at certain stages or when particular treatments are being considered.
And testing has limitations.
Sometimes no actionable biomarker is found. Sometimes a biomarker is identified, but no approved treatment specifically targets it. Even when a matching treatment exists, it may not work for everyone.
Testing can also be expensive, and insurance coverage varies.
That's why it's important to discuss which tests are appropriate, when they should be performed, and what the results might mean.
The Future: Could a Blood Test Help Track Cancer?
Researchers are investigating how circulating tumor DNA, often called ctDNA, might help detect tiny amounts of cancer remaining after treatment or identify possible recurrence.
This is sometimes called minimal residual disease testing.
The potential is exciting, but the evidence is still evolving. These tests are not yet established for every cancer, and finding a biological signal doesn't always mean doctors know the best action to take.
Scientists are also studying blood tests designed to detect multiple types of cancer before symptoms appear.
However, these tests have not been proven to replace established cancer screening methods, and their real-world benefits and limitations are still being evaluated.
It's important to distinguish what cancer medicine can do today from what researchers hope it may do tomorrow.
Five Questions Worth Asking Your Doctor
If you or someone you love has been diagnosed with cancer, consider asking:
Has my cancer been tested for biomarkers that could affect treatment?
Are there additional biomarker tests recommended for my cancer type or stage?
Could my results help identify targeted therapy, immunotherapy, or clinical trial options?
Would inherited genetic testing also be appropriate for me?
Will insurance cover the testing, and how might the results change my care plan?
You don't have to understand every scientific term.
You just need to feel comfortable asking questions until you understand your options.
The Bottom Line: The More We Know About Cancer, the More Precisely We Can Fight It.
Cancer care is becoming increasingly personal.
Doctors are learning that understanding a tumor's molecular characteristics can sometimes be just as important as knowing where the cancer began.
Biomarkers don't offer all the answers, and they don't guarantee successful treatment.
But they can provide valuable information that helps patients and healthcare teams make better-informed decisions.
And in a disease as complex as cancer, having the right information can matter.
Because knowing you have cancer is one thing. Understanding more about the cancer you have can open the door to different possibilities.
Take the Next Step
Know Your Biomarkers. Know Your Options.
Explore Touch4Life's Biomarker Toolkit to learn more about testing, understand important terms, and prepare for conversations with your healthcare team.
Sources & Further Reading
Medical Disclaimer: This article is intended for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional about biomarker testing and cancer treatment decisions.
Comments